KCTV: Renal Denervation Helping Patients Combat Hypertension
Nearly 116 million Americans are living with hypertension, more commonly known as high blood pressure. 20% of those patients have resistant hypertension - blood pressure that can’t be controlled - even with multiple medications. Resistant hypertension comes with serious risks for patients, including a substantially increased risk for heart attack, stroke, and kidney failure. Renal Denervation (RDN) is a minimally-invasive and potentially life-changing option for these patients.
KCTV5 talks with Dr. Steven Laster, interventional cardiologist at Saint Luke's Mid America Heart Institute and lead study principal investigator, about how Saint Luke’s has been the leading hospital in the region involved in this research and a major enroller in the RADIANCE II trial and how it helps patients with hypertension.
Saint Luke's patient, David Taylor, shares how this procedure has been a "game-changer and a life-saver" for him.